Search Results for "Viagra"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Viagra. Results 1 to 10 of 31 total matches.
See also: sildenafil

Viagra and Loss of Vision

   
The Medical Letter on Drugs and Therapeutics • Jun 20, 2005  (Issue 1211)
Viagra and Loss of Vision ...
The FDA recently announced that it was investigating 38 reports of loss of vision in men who took sildenafil (Viagra), which has been used to treat erectile dysfunction since 1998.
Med Lett Drugs Ther. 2005 Jun 20;47(1211):49 |  Show IntroductionHide Introduction

Vardenafil (Levitra) for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Sep 29, 2003  (Issue 1166)
. According to the manufacturer, it has a more rapid onset of action than sildenafil (Viagra − Medical Letter ...
Vardenafil (Levitra -Bayer) is the second oral drug approved by the FDA for treatment of erectile dysfunction. Sildenafil (Viagra - Medical Letter 1998; 40:51), the first oral drug, has been available for 5 years. Pharmacokinetics, effectiveness, adverse effects, dosage and cost of the new drug are reviewed. Whether it offers any benefits over sildenafil is discussed.
Med Lett Drugs Ther. 2003 Sep 29;45(1166):77-8 |  Show IntroductionHide Introduction

Sildenafil: An Oral Drug for Impotence

   
The Medical Letter on Drugs and Therapeutics • May 08, 1998  (Issue 1026)
FOR ONLINE USERS SILDENAFIL: AN ORAL DRUG FOR IMPOTENCE Sildenafil citrate (Viagra − Pfizer) is the first ...
Sildenafil citrate (Viagra - Pfizer) is the first oral drug approved by the FDA for treatment of erectile dysfunction. Alprostadil is also marketed for this indication but must be injected into the corpus cavemosum (Caverject) or pushed into the urethra (MUSE).
Med Lett Drugs Ther. 1998 May 8;40(1026):51-2 |  Show IntroductionHide Introduction

PDE5 Inhibitors for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2012  (Issue 1383)
/CMEstatus PDE5 Inhibitors for Erectile Dysfunction Sildenafil (Viagra), tadalafil (Cialis) and vardenafil ...
Sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra, Staxyn) have become the standard treatment for erectile dysfunction. Head-to-head comparisons of these agents are still lacking, but some differences between them and new recommendations for their dosing (see Table 2) are worth noting.
Med Lett Drugs Ther. 2012 Feb 6;54(1383):10-1 |  Show IntroductionHide Introduction

Sildenafil for Pulmonary Hypertension

   
The Medical Letter on Drugs and Therapeutics • Mar 01, 2004  (Issue 1177)
as Viagra for treatment of erectile dysfunction (Medical Letter 1998; 40:51). DRUG THERAPY FOR PAH ...
Several recent case reports suggest that oral sildenafil may be effective for treatment of pulmonary arterial hypertension (PAH). Sildenafil is currently marketed as Viagra for treatment of erectile dysfunction (Medical Letter 1998; 40:51).
Med Lett Drugs Ther. 2004 Mar 1;46(1177):18-9 |  Show IntroductionHide Introduction

In Brief: Testosterone and Cardiovascular Risk

   
The Medical Letter on Drugs and Therapeutics • Mar 03, 2014  (Issue 1437)
and in 167,000 given a phosphodiesterase type 5 inhibitor (sildenafil [Viagra] or tadalafil [Cialis ...
...
Med Lett Drugs Ther. 2014 Mar 3;56(1437):17 |  Show IntroductionHide Introduction

Phosphodiesterase-5 Inhibitors for Alzheimer's Disease?

   
The Medical Letter on Drugs and Therapeutics • Oct 31, 2022  (Issue 1662)
— Four PDE5 inhibitors – sildenafil (Viagra, and generics), tadalafil (Cialis, and generics ...
A reader asked us to review use of the phosphodiesterase-5 (PDE5) inhibitor sildenafil for treatment of Alzheimer's disease (AD).
Med Lett Drugs Ther. 2022 Oct 31;64(1662):174-5 |  Show IntroductionHide Introduction

Shockwave Therapy for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Nov 27, 2023  (Issue 1690)
(Viagra, and others). When a PDE5 inhibitor is ineffective or cannot be used, other treatment options ...
Low-intensity extracorporeal shockwave therapy similar to that used to fragment kidney stones or gallstones is a new option for treatment of erectile dysfunction that is now being advertised extensively in the US. It has not been approved by the FDA for treatment of erectile dysfunction.
Med Lett Drugs Ther. 2023 Nov 27;65(1690):190-1   doi:10.58347/tml.2023.1690d |  Show IntroductionHide Introduction

Eroxon — An OTC Gel for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Nov 11, 2024  (Issue 1715)
phosphodiesterase type 5 (PDE5) inhibitors such as avanafil (Stendra), sildenafil (Viagra, and generics ...
The FDA has authorized over-the-counter (OTC) sale of a nonmedicated alcohol-based gel (Eroxon – Futura) for treatment of erectile dysfunction (ED) in males ≥22 years old. Eroxon is the only FDA-approved OTC and topical treatment for erectile dysfunction. It is also available in the UK and the EU.
Med Lett Drugs Ther. 2024 Nov 11;66(1715):181-2   doi:10.58347/tml.2024.1715c |  Show IntroductionHide Introduction

Tadalafil (Cialis) for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Dec 22, 2003  (Issue 1172)
sildenafil (Viagra) or vardenafil (Levitra – Medical Letter 2003; 45:77). MECHANISM OF ACTION — Tadalafil ...
Tadalafil (Cialis - Lilly Icos) is the third oral drug to be approved by the FDA for treatment of erectile dysfunction. It has a longer duration of action than sildenafil (Viagra) or vardenafil (Levitra - Medical Letter 2003; 45:77).
Med Lett Drugs Ther. 2003 Dec 22;45(1172):101-2 |  Show IntroductionHide Introduction